Drugs / INCB013739
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00698230 | May 2008 → Apr 2009 | type 2 diabetes mellitus | Incyte Corporation | Completed | Met primary |
| Phase 2 | NCT00478322 | Apr → Nov 2007 | obesity disorder, type 2 diabetes mellitus | Incyte Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCB013739 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00478322 ↗ |
| Action | Inhibit | “The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739” PMID 20413513 ↗ Apr 2010 |